Norethisterone acetate as secondary endocrine treatment in advanced breast cancer.
da Luz
R J
RJ
ICRF Clinical Oncology Unit, Guy's Hospital, London, U.K.
Rubens
R D
RD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000188:drug therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077563:Norethindrone Acetate; D010052:Ovariectomy; D011239:Prednisolone / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D013629:Tamoxifen; D011239:Prednisolone; D000077563:Norethindrone Acetate; D009640:Norethindrone